Early stage IT and Healthcare Investing

Nanogen

portfoliocompanies

company snapshot

Nanogen

Nanogen's advanced technologies provided researchers, clinicians and physicians worldwide with improved methods and tools to predict, diagnose, and ultimately, help treat disease. The company's products included real-time PCR reagents, the NanoChip(R) 400 electronic microarray platform and a line of rapid, point-of-care diagnostic tests. Nanogen was acquired by Epoch Biosciences in 2009.

website
www.epochbio.com
Leadership
Follow The Company
Investment Team
Facebook Google+ Twitter Email LinkedIn Share